Barclays Maintains Equal-Weight on HCA Healthcare, Lowers Price Target to $387
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers the price target from $402 to $387.
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and lowers the price target from $402 to $387.